Postpartum Uterotonic Administration

• Status: Unknown status
• Trial end date: 2016-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

The investigators are planning to determine the effect of the timing of oxytocin administration on the amount of blood loss, necessity for additional medical or surgical interventions.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bagcilar Training and Research Hospital
• Collaborator: Kanuni Sultan Suleyman Training and Research Hospital
• Treatments: Oxytocin

Criteria

Inclusion Criteria:

• Cephalic presentation

• Singleton pregnancy

• Gestational age >35 weeks,

• In active labour.

• Expected fetal birth weight 2500-4500 grams.

Exclusion Criteria:

• Acute Fetal Distress

• Conversion to abdominal delivery

• Persistent high blood pressure (>140/90mmHg)

• Placenta Previa

• Ablatio placenta

• Previous C-Section

• Uterine scar

• Postpartum hemorrhage in previous pregnancies.

• Hydramnios

• Maternal infection

• Forceps/Vacuum Assisted deliveries

• Abnormal placentation ( Placenta accreta, increta or percreta)

• Coagulation Defects

• Hemoglobin < 8g/dl